NEWS
![[Hitnews] Presenting 2024 The 9th C&R Research Symposium](https://www.cnrres.com/wp-content/uploads/2021/04/CR-CI_홈페이지-기사-업로드용-300x200.png)
[Hitnews] Presenting 2024 The 9th C&R Research Symposium
2024-06-20
C&R Research (CEO Moon-Tae Yoon) announced the commencement of pre-registration for a free clinical trial symposium for pharmaceutical industry professionals,…
[Yakup] C&R Research commits to advancing clinical trials for ‘Ophthalmic Diseases’
2024-06-19
C&R Research and 'EYEBIOKOREA' signed an MOU to 'Efficiently manage clinical trials for ophthalmic diseases and enhance global clinical competitiveness'.…
[Hitnews] ‘New things, always by us!’ made C&R Research No.1 CRO in South Korea
2024-06-05
'New things, always by us!' made C&R Research No.1 CRO in South Korea. Byungjin Ahn, President of C&R Research,…
[Yakup] C&R Research and ‘Chonnam National University Hwasun Hospital’ signed an MOU to ‘Strengthen Data Utilization in Clinical Research’
2024-06-05
C&R Research and 'Chonnam National University Hwasun Hospital' signed an MOU to 'Strengthen Data Utilization in Clinical Research'. Through…
[Edaily] C&R Research led EMA approval of ‘EYELEA’ Phase 3 IND clinical trial
2024-05-29
C&R Research successfully carried out EMA approval for the Phase 3 IND clinical trial of ‘EYELEA’ Biosimilar with Rophibio, Inc.…